Comparison of antibacterial activity of fluoroquinolones with their sucralfate-complexes against clinically-isolated bacteria

Hitoshi Kawazoe, Kyoko Takaoka, Hirofumi Shibata, Naokatu Arakaki, Tomihiko Higuti, Kiyoshi Negayama, Hitoshi Houchi, Koichiro Tsuchiya, Yoshiharu Takiguchi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Oral fluoroquinolones are widely known to form chelate complexes with metal-containing drugs, resulting in inhibition of their intestinal absorption. However, for intestinal sterilization, the concomitant regimen may be a selective and effective strategy due to decreased absorption of fluoroquinolones result in the retainment of antibiotics at the intestine if the mixture still perpetuated antibacterial activity. Therefore, to clarify whether the mixture of fluoroquinolones and sucralfate affects their antibacterial activity or not, we conducted in vitro study. According from the checkerboard study using a microdilution method with Mueller-Hinton broth, the antibacterial activity of these fluoroquinolones-sucralfate mixtures equaled to the parent fluoroquinolones even in the presence of sucralfate at the molar ratio of [sucralfate : fluoroquinolone] was less than 166, and the minimal inhibitory concentrations for clinical isolated Escherichia coli and Pseudomonas aeruginosa strains were independent of the existence of sucralfate. These data imply that the chelated forms of each fluoroquinolone retain antibacterial activity even in the presence of the recommended therapeutic doses of sucralfate in clinical practice.

Original languageEnglish
Pages (from-to)790-795
Number of pages6
JournalJournal of Health Science
Volume55
Issue number5
DOIs
Publication statusPublished - 2009 Oct 1
Externally publishedYes

Fingerprint

Sucralfate
Fluoroquinolones
Bacteria
Coordination Complexes
Intestinal Absorption
Pseudomonas aeruginosa
Escherichia coli
Intestines
Metals
Anti-Bacterial Agents

Keywords

  • Antibacterial activity
  • Chelate
  • Fluoroquinolone
  • Interaction
  • Sucralfate

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Comparison of antibacterial activity of fluoroquinolones with their sucralfate-complexes against clinically-isolated bacteria. / Kawazoe, Hitoshi; Takaoka, Kyoko; Shibata, Hirofumi; Arakaki, Naokatu; Higuti, Tomihiko; Negayama, Kiyoshi; Houchi, Hitoshi; Tsuchiya, Koichiro; Takiguchi, Yoshiharu.

In: Journal of Health Science, Vol. 55, No. 5, 01.10.2009, p. 790-795.

Research output: Contribution to journalArticle

Kawazoe, H, Takaoka, K, Shibata, H, Arakaki, N, Higuti, T, Negayama, K, Houchi, H, Tsuchiya, K & Takiguchi, Y 2009, 'Comparison of antibacterial activity of fluoroquinolones with their sucralfate-complexes against clinically-isolated bacteria', Journal of Health Science, vol. 55, no. 5, pp. 790-795. https://doi.org/10.1248/jhs.55.790
Kawazoe, Hitoshi ; Takaoka, Kyoko ; Shibata, Hirofumi ; Arakaki, Naokatu ; Higuti, Tomihiko ; Negayama, Kiyoshi ; Houchi, Hitoshi ; Tsuchiya, Koichiro ; Takiguchi, Yoshiharu. / Comparison of antibacterial activity of fluoroquinolones with their sucralfate-complexes against clinically-isolated bacteria. In: Journal of Health Science. 2009 ; Vol. 55, No. 5. pp. 790-795.
@article{d10f4748226744cf9e76af997a6683b1,
title = "Comparison of antibacterial activity of fluoroquinolones with their sucralfate-complexes against clinically-isolated bacteria",
abstract = "Oral fluoroquinolones are widely known to form chelate complexes with metal-containing drugs, resulting in inhibition of their intestinal absorption. However, for intestinal sterilization, the concomitant regimen may be a selective and effective strategy due to decreased absorption of fluoroquinolones result in the retainment of antibiotics at the intestine if the mixture still perpetuated antibacterial activity. Therefore, to clarify whether the mixture of fluoroquinolones and sucralfate affects their antibacterial activity or not, we conducted in vitro study. According from the checkerboard study using a microdilution method with Mueller-Hinton broth, the antibacterial activity of these fluoroquinolones-sucralfate mixtures equaled to the parent fluoroquinolones even in the presence of sucralfate at the molar ratio of [sucralfate : fluoroquinolone] was less than 166, and the minimal inhibitory concentrations for clinical isolated Escherichia coli and Pseudomonas aeruginosa strains were independent of the existence of sucralfate. These data imply that the chelated forms of each fluoroquinolone retain antibacterial activity even in the presence of the recommended therapeutic doses of sucralfate in clinical practice.",
keywords = "Antibacterial activity, Chelate, Fluoroquinolone, Interaction, Sucralfate",
author = "Hitoshi Kawazoe and Kyoko Takaoka and Hirofumi Shibata and Naokatu Arakaki and Tomihiko Higuti and Kiyoshi Negayama and Hitoshi Houchi and Koichiro Tsuchiya and Yoshiharu Takiguchi",
year = "2009",
month = "10",
day = "1",
doi = "10.1248/jhs.55.790",
language = "English",
volume = "55",
pages = "790--795",
journal = "Journal of Health Science",
issn = "1344-9702",
publisher = "Pharmaceutical Society of Japan",
number = "5",

}

TY - JOUR

T1 - Comparison of antibacterial activity of fluoroquinolones with their sucralfate-complexes against clinically-isolated bacteria

AU - Kawazoe, Hitoshi

AU - Takaoka, Kyoko

AU - Shibata, Hirofumi

AU - Arakaki, Naokatu

AU - Higuti, Tomihiko

AU - Negayama, Kiyoshi

AU - Houchi, Hitoshi

AU - Tsuchiya, Koichiro

AU - Takiguchi, Yoshiharu

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Oral fluoroquinolones are widely known to form chelate complexes with metal-containing drugs, resulting in inhibition of their intestinal absorption. However, for intestinal sterilization, the concomitant regimen may be a selective and effective strategy due to decreased absorption of fluoroquinolones result in the retainment of antibiotics at the intestine if the mixture still perpetuated antibacterial activity. Therefore, to clarify whether the mixture of fluoroquinolones and sucralfate affects their antibacterial activity or not, we conducted in vitro study. According from the checkerboard study using a microdilution method with Mueller-Hinton broth, the antibacterial activity of these fluoroquinolones-sucralfate mixtures equaled to the parent fluoroquinolones even in the presence of sucralfate at the molar ratio of [sucralfate : fluoroquinolone] was less than 166, and the minimal inhibitory concentrations for clinical isolated Escherichia coli and Pseudomonas aeruginosa strains were independent of the existence of sucralfate. These data imply that the chelated forms of each fluoroquinolone retain antibacterial activity even in the presence of the recommended therapeutic doses of sucralfate in clinical practice.

AB - Oral fluoroquinolones are widely known to form chelate complexes with metal-containing drugs, resulting in inhibition of their intestinal absorption. However, for intestinal sterilization, the concomitant regimen may be a selective and effective strategy due to decreased absorption of fluoroquinolones result in the retainment of antibiotics at the intestine if the mixture still perpetuated antibacterial activity. Therefore, to clarify whether the mixture of fluoroquinolones and sucralfate affects their antibacterial activity or not, we conducted in vitro study. According from the checkerboard study using a microdilution method with Mueller-Hinton broth, the antibacterial activity of these fluoroquinolones-sucralfate mixtures equaled to the parent fluoroquinolones even in the presence of sucralfate at the molar ratio of [sucralfate : fluoroquinolone] was less than 166, and the minimal inhibitory concentrations for clinical isolated Escherichia coli and Pseudomonas aeruginosa strains were independent of the existence of sucralfate. These data imply that the chelated forms of each fluoroquinolone retain antibacterial activity even in the presence of the recommended therapeutic doses of sucralfate in clinical practice.

KW - Antibacterial activity

KW - Chelate

KW - Fluoroquinolone

KW - Interaction

KW - Sucralfate

UR - http://www.scopus.com/inward/record.url?scp=70350222049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350222049&partnerID=8YFLogxK

U2 - 10.1248/jhs.55.790

DO - 10.1248/jhs.55.790

M3 - Article

AN - SCOPUS:70350222049

VL - 55

SP - 790

EP - 795

JO - Journal of Health Science

JF - Journal of Health Science

SN - 1344-9702

IS - 5

ER -